Skip to main content
. 2024 Jan 9;409(1):32. doi: 10.1007/s00423-023-03217-4

Table 1.

Patient, clinical and operative characteristics. Continuous variables are mean ± standard deviation, categorical variables are n (%)

All (n = 168) Benign (n = 102) Malignant (n = 66) P value
Age 68 ± 13 66 ± 13 71 ± 11 0.043
Male sex 101 (60.1%) 59 (57.8%) 42 (63.6%) 0.454
BMI, kg/m2 27 ± 3 27 ± 3 27 ± 3 0.488
ASA 0.004
  I 27 (16.1%) 23 (22.5%) 4 (6.1%)
  II 78 (46.4%) 50 (49.0%) 28 (42.4%)
  III 62 (36.9%) 29 (28.4%) 33 (50.0%)
Pre-TAMIS polypectomy 33 (19.6%) 15 (14.7%) 18 (27.3%) 0.045
Size (mm) 48 ± 23 52 ± 23 41 ± 22 0.005
Distance to anal verge (cm) 6 ± 4 6 ± 4 6 ± 4 0.752
Final pathology
Benign 102 (60.7%)
  Adenoma n 100 (59.5%)
  Other n 2 (1.2%)
Malignant 66 (39.3%)
  Adenocarcinoma n 59 (35.1%)
  ypT0 4 (2.4%)
  ypT1 3 (1.8%)
  ypT2 1 (0.6%)
  pT1 38 (22.6%)
  pT2 13 (7.7%)
  Carcinoid 6 (3.6%)
  Maltoma 1 (0.6%)
Negative margin (R0) 160 (95.2%) 97 (95.1%) 63 (95.5%) 0.916
Resection depth 0.496
Full thickness 133 (79.2%) 79 (77.5%) 54 (81.8%)
Submucosal 35 (20.8%) 23 (22.5%) 12 (18.2%)
Tumour fragmentation 6 (3.6%) 4 (3.9%) 2 (3.1%) 0.775
Defect closure 161 (95.8%) 97 (95.1%) 64 (97.0%) 0.553